Researchers say preliminary research suggests that a popular non-psychoactive compound derived from marijuana may help prevent or treat COVID-19 warrants treatment.
Several recent cannabidiol, or CBD, laboratory studies have received promising results, garnering media attention.
However, several other potential COVID treatments that showed promise in test tubes, from hydroxychloroquine to various cancer and other disease treatments, ultimately failed to show benefit for COVID-19 patients when studied in clinical trials.